Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: Torben Noerup Nielsen who wrote (30209)	1/13/2000 12:53:00 PM
From: Mudcat	Read Replies (1) \| Respond to of 32384

Toben, although I have been labeled a nay-sayer, in reality I bought this stock over 3 years ago and have not sold any since. I did unload my warrants a few days ago. Otherwise I have been long on the stock. I just like both sides of the story to be told and Hank does not do that. I have asked him many times over the past 3 years how many shares he has bought and sold in Lgnd but he refuses to answer. Why, because he was given many shares in the company and he hypes to get the price up to sell them. Although he has a vast knowledge of the science, he only comments on positives because of his stock position.

To: Torben Noerup Nielsen who wrote (30209)	1/13/2000 1:05:00 PM
From: Henry Niman	Read Replies (2) \| Respond to of 32384

Naysayers also have a tendency to keep repeating their false information. Although I have commented on the speed with which LGND got Panretin approved (published discovery in 1992 and had FDA approval in 1999), I don't think I ever commented on future (or past) sales. Of course the rest of the speculation is a notch below false speculations. Regarding the science behind Panretin, I have commented many times on differences between LGND's various products, and in some cases such explanations appear to have fallen on deaf ears. When LGND found activity of Panretin against KS, there were no approved protease inhibitors, which have changed the makeup of AIDS patients population quite significantly.

To: Torben Noerup Nielsen who wrote (30209)	1/13/2000 1:28:00 PM
From: Henry Niman	Respond to of 32384

Well not everyone on the board is flippant. Some actually put in writing charges of stock price manipulation (a little ignoring goes a long way): <<because he was given many shares in the company and he hypes to get the price up to sell them>> I guess even my "naysayer ignore" button doesn't prevent others from making serious accusations that could leave them legally exposed. However, I think that the legal requirement is that the false accusation is knowingly published as false, and it's clear that it would be very difficult to prove knowledge of much of anything by some posters on this board.